It is very important for South Australia, and thusly for SAHMRI to have a fiery and exceptionally beneficial system of research in mind-body incorporates and advances research over the new world-class SAHMRI facility and their three colleges, in association with the wellbeing division.



Professor Julio Licinio is delighted to have been designated as the inaugural pioneer for the Mind - Brain Theme, and Deputy Director for Translational Medicine at SAHMRI. Professor Julio Licinio's research gathering's zones of examination incorporate chronic stress, obesity, depression and their interface. Depression is the main source of non-lethal illness trouble in Australia and suicide, regularly a result of misery, speaks to the third most noteworthy reason for fatal disease burden in Australian men.

One of the key investigative objectives of SAHMRI's Mind and Brain Theme is to make an interpretation of pharmacogenomics of antidepressants to customized medications for despondency. In term of their own gathering's exploration, they have had a considerable spotlight on pharmacogenomics of antidepressants - that, understands why antidepressants can work so well for a few people, while having no consequences for others.

Since 1999 there has been an inexorably huge collection of exploration attempting to recognize hereditary indicators of stimulant reaction. As one of the inaugural subsidized individuals from the US National Institutes of Health Pharmacogenetics Research Network, they have been an exceptionally dynamic part of the exertion went for distinguishing, in an exploration setting, hereditary biomarkers of energizer reaction. Presently, comparably to what is occurring in growth, the time has come to decipher this work from the domain of immaculate examination to that of clinical consideration.



They are especially energized by the likelihood of considering, all things considered, settings hereditary qualities guided treatment, which is opportune, tour shangrila truly energizing and genuinely necessary. This genuinely translational line of examination is gone for looking at in a planned, randomized way the results of pharmacotherapy, which is guided by information of the individual's genotype versus routine treatment. This kind of very much controlled, planned genuine living, translational study has been prescribed as a high need by a US Centers for Disease Control and Prevention board that analyzed whether pharmacogenomics of antidepressants is prepared for clinical use. The conclusion from the board is that it presently was not, on account of this kind of study has not yet been directed. We are prepared for that kind of concentrate now - leading this sort of examination in Australia will put us at the highest point of the field around the world.

A brief about Julio Licinio

Julio Licinio lived in the United States for a long time, say about 25 years, yet he got his MD from the Federal University of Bahia in 1982, and finished his residency in internal medicine at the University of Sao Paulo from 1982 to 1984. He then moved to the United States and finished preparing in endocrinology at The University of Chicago, and psychiatry at Albert Einstein in the Bronx and also at Weill Cornell Medical College. Licinio is enrolled as an authority in psychiatry by the Australian Health Practitioner Regulation Agency.












Julio Licinio lived in the United States for a long time, say about 25 years, yet he got his MD from the Federal University of Bahia in 1982, and finished his residency in internal medicine at the University of Sao Paulo from 1982 to 1984. He then moved to the United States and finished preparing in endocrinology at The University of Chicago, and psychiatry at Albert Einstein in the Bronx and also at Weill Cornell Medical College. Licinio is enrolled as an authority in psychiatry by the Australian Health Practitioner Regulation Agency.